| Name: | Lacosamide EP Impurity E |
| Catalogue No. | VL1250014 |
| CAS No. | 175481-39-7 |
| Molecular Formula | C10H14N2O2 |
| Molecular Weight | 194.23 |
| Status | In-stock |
| IUPAC Name | (2E)-2-amino-N-benzyl-3-hydroxypropanamide |
| Synonyms | Lacosamide N-Desacetyl O-Desmethyl Impurity |
| Appearance | Light Yellow Powder |
| Description | Lacosamide EP Impurity E (CAS No: 175481-39-7) Or (2E)-2-amino-N-benzyl-3-hydroxypropanamide, Lacosamide used as adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. which is a potent anticonvulsant. |
| References | Sci-Hub | A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs | 10.2165/11587550-000000000-00000. (2021). Retrieved December 11, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.2165/11587550-000000000-00000 |
